181 related articles for article (PubMed ID: 28958073)
1. Five-year results of patients supported by HeartMate II: outcomes and adverse events.
Hanke JS; Rojas SV; Mahr C; Schmidt AF; Zoch A; Dogan G; Feldmann C; Deniz E; Molitoris U; Bara C; Strüber M; Haverich A; Schmitto JD
Eur J Cardiothorac Surg; 2018 Feb; 53(2):422-427. PubMed ID: 28958073
[TBL] [Abstract][Full Text] [Related]
2. Use of left ventricular assist device (HeartMate II): a Singapore experience.
Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
[TBL] [Abstract][Full Text] [Related]
3. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
[TBL] [Abstract][Full Text] [Related]
4. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
[TBL] [Abstract][Full Text] [Related]
5. Post-heart transplantation outcome of HeartMate II-bridged recipients requiring unplanned concomitant temporary right ventricular mechanical support.
Urban M; Pirk J; Szarszoi O; Besik J; Netuka I
Interact Cardiovasc Thorac Surg; 2015 Mar; 20(3):372-8. PubMed ID: 25487235
[TBL] [Abstract][Full Text] [Related]
6. Experience with the HeartMate II Left Ventricular Assist Device in Patients Older than 60 Years.
Demirozu ZT; Critsinelis A; Cohn WE; Radovancevic R; Ho J; Hernandez R; Morgan JA; Frazier OH
Heart Surg Forum; 2019 Mar; 22(2):E124-E130. PubMed ID: 31013222
[TBL] [Abstract][Full Text] [Related]
7. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.
Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Acker MA; Goldstein DL; Silvestry SC; Milano CA; Baldwin JT; Pinney S; Eduardo Rame J; Miller MA
J Heart Lung Transplant; 2014 Jan; 33(1):12-22. PubMed ID: 24418730
[TBL] [Abstract][Full Text] [Related]
8. The association of pretransplant HeartMate II left ventricular assist device placement and heart transplantation mortality.
Donneyong M; Cheng A; Trivedi JR; Schumer E; McCants KC; Birks EJ; Slaughter MS
ASAIO J; 2014; 60(3):294-9. PubMed ID: 24614355
[TBL] [Abstract][Full Text] [Related]
9. Utility of cardiac computed tomography for inflow cannula patency assessment and prediction of clinical outcome in patients with the HeartMate II left ventricular assist device.
Sacks J; Gonzalez-Stawinski GV; Hall S; Lima B; MacHannaford J; Dockery W; Cura M; Chamogeorgakis T
Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):590-3. PubMed ID: 26223857
[TBL] [Abstract][Full Text] [Related]
10. More than 20 years' experience of left ventricular assist device implantation at a non-transplant Centre.
Holmberg E; Ahn H; Peterzén B
Scand Cardiovasc J; 2017 Dec; 51(6):293-298. PubMed ID: 29029567
[TBL] [Abstract][Full Text] [Related]
11. First series of left ventricular assist device exchanges to HeartMate 3.
Hanke JS; Rojas SV; Dogan G; Feldmann C; Beckmann E; Deniz E; Wiegmann B; Michaelis JE; Napp LC; Berliner D; Shrestha M; Bauersachs J; Haverich A; Schmitto JD
Eur J Cardiothorac Surg; 2017 May; 51(5):887-892. PubMed ID: 28329060
[TBL] [Abstract][Full Text] [Related]
12. One-year outcomes with the HeartMate 3 left ventricular assist device.
Hanke JS; Dogan G; Zoch A; Ricklefs M; Wert L; Feldmann C; Bara C; Shrestha M; Tillmanns J; Kempf T; Bauersachs J; Haverich A; Schmitto JD
J Thorac Cardiovasc Surg; 2018 Aug; 156(2):662-669. PubMed ID: 29525258
[TBL] [Abstract][Full Text] [Related]
13. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients.
Boyle AJ; Jorde UP; Sun B; Park SJ; Milano CA; Frazier OH; Sundareswaran KS; Farrar DJ; Russell SD;
J Am Coll Cardiol; 2014 Mar; 63(9):880-8. PubMed ID: 24316083
[TBL] [Abstract][Full Text] [Related]
14. Clinical impact of atrial fibrillation in patients with the HeartMate II left ventricular assist device.
Enriquez AD; Calenda B; Gandhi PU; Nair AP; Anyanwu AC; Pinney SP
J Am Coll Cardiol; 2014 Nov; 64(18):1883-90. PubMed ID: 25444141
[TBL] [Abstract][Full Text] [Related]
15. Cardiac recovery following left ventricular assist device therapy: experience of complete device explantation including ventricular patch plasty.
Gyoten T; Rojas SV; Fox H; Hata M; Deutsch MA; Schramm R; Gummert JF; Morshuis M
Eur J Cardiothorac Surg; 2021 Apr; 59(4):855-862. PubMed ID: 33367693
[TBL] [Abstract][Full Text] [Related]
16. Impact of concurrent surgical valve procedures in patients receiving continuous-flow devices.
John R; Naka Y; Park SJ; Sai-Sudhakar C; Salerno C; Sundareswaran KS; Farrar DJ; Milano CA
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):581-9; discussion 589. PubMed ID: 24418362
[TBL] [Abstract][Full Text] [Related]
17. Adverse neurologic events in patients bridged with long-term mechanical circulatory support: A device-specific comparative analysis.
Coffin ST; Haglund NA; Davis ME; Xu M; Dunlay SM; Cowger JA; Shah P; Aaronson KD; Pagani FD; Stulak JM; Maltais S;
J Heart Lung Transplant; 2015 Dec; 34(12):1578-85. PubMed ID: 26522376
[TBL] [Abstract][Full Text] [Related]
18. Major bleeding during HeartMate II support.
Bunte MC; Blackstone EH; Thuita L; Fowler J; Joseph L; Ozaki A; Starling RC; Smedira NG; Mountis MM
J Am Coll Cardiol; 2013 Dec; 62(23):2188-96. PubMed ID: 23994419
[TBL] [Abstract][Full Text] [Related]
19. Early elevations in pump power with the HeartMate II left ventricular assist device do not predict late adverse events.
Salerno CT; Sundareswaran KS; Schleeter TP; Moanie SL; Farrar DJ; Walsh MN
J Heart Lung Transplant; 2014 Aug; 33(8):809-15. PubMed ID: 24735680
[TBL] [Abstract][Full Text] [Related]
20. De Novo Human Leukocyte Antigen Allosensitization in Heartmate 3 Versus Heartmate II Left Ventricular Assist Device Recipients.
Jain R; Habal MV; Clerkin KJ; Latif F; Restaino SW; Zorn E; Takeda K; Naka Y; Yuzefpolskaya M; Farr MA; Colombo PC; Sayer GT; Uriel N; Topkara VK
ASAIO J; 2022 Feb; 68(2):226-232. PubMed ID: 33883507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
